Tesetaxel: Phase II started

Genta began an open label, dose-escalating, international Phase II trial to evaluate 50 mg

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE